Search results
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...
Simply Wall St. via Yahoo Finance· 7 hours agoAs you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest...
Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoVertex Pharmaceuticals (NASDAQ:VRTX) First Quarter 2024 Results Key Financial Results Revenue:...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 15 hours agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 1 day agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics - Vertex Pharmaceuticals...
Benzinga· 1 day agoLoading... Loading... Financial giants have made a conspicuous bullish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex ...
Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Pr
Guru Focus· 1 day agoVertex Pharmaceuticals Inc (VRTX, Financial) recently showcased a daily gain of 2.86%, despite a slight 3-month loss of 0.7%. This article delves into the ...
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): Director Sangeeta Bhatia Sells Shares
GuruFocus.com via Yahoo Finance· 6 days agoOn May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX)...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 ...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 8 hours agoThe stock market rally had a quiet session for a second straight day. Nvidia fell slightly for a...
Vertex Pharmaceuticals (NASDAQ:VRTX) Raised to “Strong-Buy” at StockNews.com
ETF DAILY NEWS· 4 days agoBarclays raised their price objective on shares of Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an overweight rating in a research ...